The DOI matches its Crossref record.
Extracorporeal cardiac shock wave therapy ameliorates myocardial ischemia in patients with severe coronary artery disease
Abstract
In Brief Objective Prognosis of severe coronary artery disease with no indication of percutaneous coronary intervention or coronary artery bypass grafting remains poor. We have recently demonstrated that shock wave therapy effectively induces neovascularization and improves myocardial ischemia in a porcine model in vivo. Methods With permission from the Ethical Committee of our Institute, we treated nine patients with end-stage coronary artery disease with no indication of percutaneous coronary intervention or coronary artery bypass grafting (55–82 years old, five men and four women) with our cardiac shock wave therapy (200 shots/spot at 0.09 mJ/mm2 for 20–40 spots, 3 times a week/series). We followed-up the patients at 1, 3, 6, and 12 months after the therapy to examine the amelioration of myocardial ischemia. When needed, shock wave therapy was performed up to three series at 0, and 1, 3 or 6 months. Results The cardiac shock wave therapy improved symptoms (Canadian Cardiovascular Society functional class score, from 2.7±0.2 to 1.8±0.2, P<0.01) and reduced nitroglycerin use (from 5.4±2.5 to 0.3±0.3/week, P<0.05). The treatment also improved myocardial perfusion as assessed by dipyridamole stress thallium scintigraphy (severity score, 25.2±7.2% improvement, P<0.05; extent score, 23.3±9.0% improvement, P=0.10; washout rate, 20±3 to 34±3, P<0.05). Myocardial perfusion was improved only in the ischemic area treated with the therapy. These beneficial effects persisted for 12 months. No procedural complications or adverse effects were noted. Conclusion These results indicate that our extracorporeal cardiac shock wave therapy is an effective and non-invasive treatment for end-stage coronary artery disease, although further careful evaluation is needed. Prognosis of severe coronary artery disease with no indication of percutaneous coronary intervention or coronary artery bypass grafting remains poor. We have recently demonstrated that shock wave therapy effectively induces neovascularization and improvesmyocardial ischemia in a porcinemodel in vivo. The aimof this study was to test this notion in patients with severe coronary artery disease. We treated nine patients with severe coronary artery disease with our cardiac shock wave therapy. We followed-up the patients at 1, 3, 6, and 12 months after the therapy to examine the amelioration ofmyocardial ischemia. When needed, shock wave therapy was performed up to three series at 0, and 1, 3 or 6 months. The cardiac shock wave therapy improved symptoms, nitroglycerin use, andmyocardial perfusion as assessed by dipyridamole stress thallium scintigraphy. These beneficial effects persisted for 12 months. No procedural complications or adverse effects were noted. These results suggest that our extracorporeal cardiac shock wave therapy is an effective and non-invasive treatment for severe coronary artery disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
2013 ESC guidelines on the management of stable coronary artery disease
Task Force Members, Montalescot, G., Sechtem, U., Achenbach, S., Andreotti, F., Arden, C., Budaj, A., Bugiardini, R., Crea, F., Cuisset, T., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht296 · Cited by 4,510
Aicher, A., Heeschen, C., Sasaki, K.-I., Urbich, C., Zeiher, A. M., & Dimmeler, S. (2006) · Circulation · doi:10.1161/circulationaha.106.628623 · Cited by 316
Mechanisms of Primary Blast-Induced Traumatic Brain Injury: Insights from Shock-Wave Research
Nakagawa, A., Manley, G. T., Gean, A. D., Ohtani, K., Armonda, R., Tsukamoto, A., Yamamoto, H., Takayama, K., & Tominaga, T. (2011) · Journal of Neurotrauma · doi:10.1089/neu.2010.1442 · Cited by 269
Mariotto, S., de Prati, A., Cavalieri, E., Amelio, E., Marlinghaus, E., & Suzuki, H. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709788682119 · Cited by 265
Metadata
- Authors
- Fukumoto, Y., Ito, A., Uwatoku, T., Matoba, T., Kishi, T., Tanaka, H., Takeshita, A., Sunagawa, K., & Shimokawa, H.
- Venue
- Coronary Artery Disease
- Published
- 2006-02
- Volume
- 17
- Issue
- 1
- Pages
- 63-70
- ISSN
- 0954-6928 (ISSN-L)
- OpenAlex
- W2114063322
- Cited by
- 191
- References
- 0
- FWCI
- 2.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Extracorporeal cardiac shock wave therapy ameliorates myocardial ischemia in patients with severe coronary artery disease. https://app.cochat.ai/papers/10.1097/00019501-200602000-00011
- The paper
- Fukumoto, Y., Ito, A., Uwatoku, T., Matoba, T., Kishi, T., Tanaka, H., Takeshita, A., Sunagawa, K., & Shimokawa, H. (2006). Extracorporeal cardiac shock wave therapy ameliorates myocardial ischemia in patients with severe coronary artery disease. Coronary Artery Disease. https://doi.org/10.1097/00019501-200602000-00011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.